[HTML][HTML] Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity

DK Cole, AM Bulek, G Dolton… - The Journal of …, 2016 - Am Soc Clin Investig
DK Cole, AM Bulek, G Dolton, AJ Schauenberg, B Szomolay, W Rittase, A Trimby…
The Journal of clinical investigation, 2016Am Soc Clin Investig
The cross-reactivity of T cells with pathogen-and self-derived peptides has been implicated
as a pathway involved in the development of autoimmunity. However, the mechanisms that
allow the clonal T cell antigen receptor (TCR) to functionally engage multiple peptide–major
histocompatibility complexes (pMHC) are unclear. Here, we studied multiligand
discrimination by a human, preproinsulin reactive, MHC class-I–restricted CD8+ T cell clone
(1E6) that can recognize over 1 million different peptides. We generated high-resolution …
The cross-reactivity of T cells with pathogen- and self-derived peptides has been implicated as a pathway involved in the development of autoimmunity. However, the mechanisms that allow the clonal T cell antigen receptor (TCR) to functionally engage multiple peptide–major histocompatibility complexes (pMHC) are unclear. Here, we studied multiligand discrimination by a human, preproinsulin reactive, MHC class-I–restricted CD8+ T cell clone (1E6) that can recognize over 1 million different peptides. We generated high-resolution structures of the 1E6 TCR bound to 7 altered peptide ligands, including a pathogen-derived peptide that was an order of magnitude more potent than the natural self-peptide. Evaluation of these structures demonstrated that binding was stabilized through a conserved lock-and-key–like minimal binding footprint that enables 1E6 TCR to tolerate vast numbers of substitutions outside of this so-called hotspot. Highly potent antigens of the 1E6 TCR engaged with a strong antipathogen-like binding affinity; this engagement was governed though an energetic switch from an enthalpically to entropically driven interaction compared with the natural autoimmune ligand. Together, these data highlight how T cell cross-reactivity with pathogen-derived antigens might break self-tolerance to induce autoimmune disease.
The Journal of Clinical Investigation